At Diversified Chemical Products, Inc. (DCP), we offer our clientele an unique blend of products and services. Services offered consist of private label programs, contract packaging, toll blending of liquids, powders and pastes, formulation services, product modification and warehousing/product storage. Packaging capabilities from drums, pails, bottles, cylinders, jars, tubes to unit dose packets. Formulas available for private label include enzymatic cleaning solutions, ultrasonic cleaning solutions, evacuation system cleaners, instrument cleaners, tartar & stain removers, denture cleansers, autoclave cleaners, cement removers (permanent/temporary), plaster & stone removers, heat shield putty, alginate removers, jewelry cleaners, polishing compounds, die lubricant, hand piece cleaner, release agents, metal cleaners/brighteners, general purpose cleaners and scale removers. One time packaging and small runs are welcome. With DCP, outsourcing you chemistries just got easier!
Very common (10% or more): Extrapyramidal disorder (up to 34%), hyperkinesia (up to 13%), headache (up to 12%)
Common (1% to 10%): Tardive dyskinesia, dystonia, dyskinesia, akathisia, bradykinesia, hypertonia, somnolence, masked facies, tremor, dizziness, parkinsonism/parkinsonian effects
Uncommon (% to 1%): Convulsion, akinesia, cogwheel rigidity, sedation, involuntary muscle contractions, gait disturbance, persistent tardive dyskinesia
Rare (% to %): Motor dysfunction, neuroleptic malignant syndrome, nystagmus
Frequency not reported: Drowsiness, epileptic/grand mal seizure, vertigo, lethargy
Postmarketing reports: Opisthotonos [ Ref ]
Haloperidol is a typical butyrophenone type antipsychotic that exhibits high affinity dopamine D 2 receptor antagonism and slow receptor dissociation kinetics.  It has effects similar to the phenothiazines .  The drug binds preferentially to D 2 and α 1 receptors at low dose (ED 50 = and mg/kg, respectively), and 5-HT 2 receptors at a higher dose (ED 50 = mg/kg). Given that antagonism of D 2 receptors is more beneficial on the positive symptoms of schizophrenia and antagonism of 5-HT 2 receptors on the negative symptoms, this characteristic underlies haloperidol's greater effect on delusions, hallucinations and other manifestations of psychosis.  Haloperidol's negligible affinity for histamine H 1 receptors and muscarinic M 1 acetylcholine receptors yields an antipsychotic with a lower incidence of sedation, weight gain, and orthostatic hypotension though having higher rates of treatment emergent extrapyramidal symptoms .